## Process
GO term | Description | P-value | FDR q-value | Enrichment (N, B, n, b) |
 ---    |     ---     | ---     | ---         | ---                     |  
GO:0055085 | transmembrane transport | 1.57E-38 | 2.44E-34 | 2.58 (18547,1255,1181,206) | 
GO:0009987 | cellular process | 1.29E-36 | 1.01E-32 | 1.19 (18547,13737,1181,1045) | 
GO:0034220 | ion transmembrane transport | 4.02E-33 | 2.08E-29 | 2.80 (18547,875,1181,156) | 
GO:0008150 | biological_process | 5.85E-33 | 2.27E-29 | 1.08 (18547,16925,1181,1169) | 
GO:0006811 | ion transport | 8.81E-33 | 2.74E-29 | 2.42 (18547,1280,1181,197) | 
GO:0048856 | anatomical structure development | 3.62E-32 | 9.38E-29 | 1.78 (18547,3237,1181,366) | 
GO:0016043 | cellular component organization | 5.16E-32 | 1.14E-28 | 1.56 (18547,5052,1181,503) | 
GO:0071840 | cellular component organization or biogenesis | 5.91E-31 | 1.15E-27 | 1.55 (18547,5098,1181,503) | 
GO:0032502 | developmental process | 5.21E-30 | 9E-27 | 1.56 (18547,4822,1181,480) | 
GO:0060271 | cilium assembly | 4.15E-29 | 6.44E-26 | 5.08 (18547,201,1181,65) | 
GO:0098655 | cation transmembrane transport | 1.18E-27 | 1.67E-24 | 3.04 (18547,594,1181,115) | 
GO:0044782 | cilium organization | 2.15E-27 | 2.78E-24 | 4.71 (18547,220,1181,66) | 
GO:0006812 | cation transport | 8.69E-27 | 1.04E-23 | 2.67 (18547,799,1181,136) | 
GO:1902600 | proton transmembrane transport | 1.57E-26 | 1.74E-23 | 5.89 (18547,136,1181,51) | 
GO:0051179 | localization | 4.58E-26 | 4.74E-23 | 1.53 (18547,4684,1181,457) | 
GO:0006996 | organelle organization | 5.96E-26 | 5.79E-23 | 1.87 (18547,2251,1181,268) | 
GO:0015672 | monovalent inorganic cation transport | 7.49E-26 | 6.84E-23 | 3.54 (18547,386,1181,87) | 
GO:0009653 | anatomical structure morphogenesis | 1.5E-25 | 1.3E-22 | 2.18 (18547,1364,1181,189) | 
GO:0098660 | inorganic ion transmembrane transport | 5.57E-25 | 4.56E-22 | 2.86 (18547,627,1181,114) | 
GO:0032501 | multicellular organismal process | 8.67E-25 | 6.73E-22 | 1.65 (18547,3391,1181,356) | 
GO:0098662 | inorganic cation transmembrane transport | 4.18E-24 | 3.09E-21 | 2.98 (18547,543,1181,103) | 
GO:0007389 | pattern specification process | 2.43E-23 | 1.72E-20 | 3.45 (18547,369,1181,81) | 
GO:0120031 | plasma membrane bounded cell projection assembly | 1E-22 | 6.76E-20 | 3.78 (18547,291,1181,70) | 
GO:0033108 | mitochondrial respiratory chain complex assembly | 2.83E-22 | 1.83E-19 | 6.63 (18547,90,1181,38) | 
GO:0030031 | cell projection assembly | 3.8E-22 | 2.36E-19 | 3.66 (18547,305,1181,71) | 
GO:0048513 | animal organ development | 1.08E-21 | 6.46E-19 | 2.14 (18547,1227,1181,167) | 
GO:0044281 | small molecule metabolic process | 7.09E-21 | 4.08E-18 | 1.91 (18547,1712,1181,208) | 
GO:0051234 | establishment of localization | 1.16E-20 | 6.42E-18 | 1.50 (18547,4207,1181,403) | 
GO:0006810 | transport | 2.11E-20 | 1.13E-17 | 1.51 (18547,4084,1181,393) | 
GO:0017004 | cytochrome complex assembly | 3.67E-20 | 1.9E-17 | 10.62 (18547,34,1181,23) | 
GO:0048598 | embryonic morphogenesis | 9.85E-20 | 4.94E-17 | 3.09 (18547,401,1181,79) | 
GO:0070286 | axonemal dynein complex assembly | 1.55E-18 | 7.52E-16 | 10.64 (18547,31,1181,21) | 
GO:0070925 | organelle assembly | 4.66E-18 | 2.19E-15 | 2.74 (18547,499,1181,87) | 
GO:0022607 | cellular component assembly | 2.36E-17 | 1.08E-14 | 1.67 (18547,2328,1181,248) | 
GO:0042776 | mitochondrial ATP synthesis coupled proton transport | 5.36E-17 | 2.38E-14 | 13.22 (18547,19,1181,16) | 
GO:0015985 | energy coupled proton transport, down electrochemical gradient | 8.1E-17 | 3.49E-14 | 12.14 (18547,22,1181,17) | 
GO:0015986 | ATP synthesis coupled proton transport | 8.1E-17 | 3.4E-14 | 12.14 (18547,22,1181,17) | 
GO:0120036 | plasma membrane bounded cell projection organization | 1.2E-16 | 4.9E-14 | 2.52 (18547,573,1181,92) | 
GO:0009887 | animal organ morphogenesis | 1.72E-16 | 6.86E-14 | 2.68 (18547,481,1181,82) | 
GO:1901135 | carbohydrate derivative metabolic process | 1.75E-16 | 6.8E-14 | 2.19 (18547,861,1181,120) | 
GO:0099132 | ATP hydrolysis coupled cation transmembrane transport | 1.89E-16 | 7.15E-14 | 7.04 (18547,58,1181,26) | 
GO:1901137 | carbohydrate derivative biosynthetic process | 3.28E-16 | 1.21E-13 | 2.73 (18547,449,1181,78) | 
GO:0030030 | cell projection organization | 4.25E-16 | 1.53E-13 | 2.26 (18547,766,1181,110) | 
GO:0006091 | generation of precursor metabolites and energy | 5.66E-16 | 2E-13 | 2.94 (18547,363,1181,68) | 
GO:0008535 | respiratory chain complex IV assembly | 9.42E-16 | 3.25E-13 | 11.12 (18547,24,1181,17) | 
GO:0007007 | inner mitochondrial membrane organization | 2.64E-15 | 8.9E-13 | 8.24 (18547,40,1181,21) | 
GO:0009799 | specification of symmetry | 3.2E-15 | 1.06E-12 | 6.15 (18547,69,1181,27) | 
GO:0006119 | oxidative phosphorylation | 4.62E-15 | 1.5E-12 | 9.75 (18547,29,1181,18) | 
GO:0042407 | cristae formation | 4.62E-15 | 1.47E-12 | 9.75 (18547,29,1181,18) | 
GO:0007018 | microtubule-based movement | 5.96E-15 | 1.85E-12 | 3.27 (18547,259,1181,54) | 
GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen | 9.5E-15 | 2.89E-12 | 12.93 (18547,17,1181,14) | 
GO:0019646 | aerobic electron transport chain | 9.5E-15 | 2.84E-12 | 12.93 (18547,17,1181,14) | 
GO:0007368 | determination of left/right symmetry | 1.32E-14 | 3.87E-12 | 6.09 (18547,67,1181,26) | 
GO:0009855 | determination of bilateral symmetry | 2.01E-14 | 5.78E-12 | 6.00 (18547,68,1181,26) | 
GO:0007224 | smoothened signaling pathway | 6.72E-14 | 1.9E-11 | 5.75 (18547,71,1181,26) | 
GO:0003008 | system process | 8.08E-14 | 2.24E-11 | 1.80 (18547,1407,1181,161) | 
GO:0051641 | cellular localization | 1.12E-13 | 3.04E-11 | 1.62 (18547,2114,1181,218) | 
GO:0044255 | cellular lipid metabolic process | 1.68E-13 | 4.49E-11 | 2.01 (18547,923,1181,118) | 
GO:0006839 | mitochondrial transport | 1.83E-13 | 4.81E-11 | 4.20 (18547,131,1181,35) | 
GO:0006629 | lipid metabolic process | 2.7E-13 | 7E-11 | 1.87 (18547,1168,1181,139) | 
GO:1905515 | non-motile cilium assembly | 4.16E-13 | 1.06E-10 | 7.14 (18547,44,1181,20) | 
GO:0007017 | microtubule-based process | 4.66E-13 | 1.17E-10 | 2.27 (18547,603,1181,87) | 
GO:1990542 | mitochondrial transmembrane transport | 5.37E-13 | 1.32E-10 | 4.79 (18547,95,1181,29) | 
GO:0003341 | cilium movement | 6.89E-13 | 1.67E-10 | 6.28 (18547,55,1181,22) | 
GO:0097502 | mannosylation | 7.9E-13 | 1.89E-10 | 7.85 (18547,36,1181,18) | 
GO:0008610 | lipid biosynthetic process | 1.04E-12 | 2.44E-10 | 2.31 (18547,550,1181,81) | 
GO:0006820 | anion transport | 2.36E-12 | 5.48E-10 | 2.32 (18547,528,1181,78) | 
GO:0007601 | visual perception | 2.89E-12 | 6.61E-10 | 3.35 (18547,197,1181,42) | 
GO:0050953 | sensory perception of light stimulus | 5.81E-12 | 1.31E-9 | 3.28 (18547,201,1181,42) | 
GO:0045333 | cellular respiration | 8.11E-12 | 1.8E-9 | 5.66 (18547,61,1181,22) | 
GO:0009888 | tissue development | 8.3E-12 | 1.82E-9 | 2.20 (18547,593,1181,83) | 
GO:0015980 | energy derivation by oxidation of organic compounds | 8.74E-12 | 1.89E-9 | 3.99 (18547,126,1181,32) | 
GO:0022904 | respiratory electron transport chain | 9.55E-12 | 2.03E-9 | 4.61 (18547,92,1181,27) | 
GO:0033617 | mitochondrial respiratory chain complex IV assembly | 1.35E-11 | 2.84E-9 | 10.21 (18547,20,1181,13) | 
GO:0036158 | outer dynein arm assembly | 1.93E-11 | 4E-9 | 11.09 (18547,17,1181,12) | 
GO:0009060 | aerobic respiration | 2.13E-11 | 4.36E-9 | 6.73 (18547,42,1181,18) | 
GO:0046034 | ATP metabolic process | 3.9E-11 | 7.86E-9 | 4.10 (18547,111,1181,29) | 
GO:0003002 | regionalization | 5.75E-11 | 1.15E-8 | 2.93 (18547,241,1181,45) | 
GO:0050877 | nervous system process | 5.9E-11 | 1.16E-8 | 1.88 (18547,927,1181,111) | 
GO:0042733 | embryonic digit morphogenesis | 6.07E-11 | 1.18E-8 | 5.71 (18547,55,1181,20) | 
GO:0003352 | regulation of cilium movement | 7.18E-11 | 1.38E-8 | 11.52 (18547,15,1181,11) | 
GO:1901576 | organic substance biosynthetic process | 8.42E-11 | 1.6E-8 | 1.49 (18547,2419,1181,230) | 
GO:0019637 | organophosphate metabolic process | 9.91E-11 | 1.86E-8 | 1.89 (18547,889,1181,107) | 
GO:0035239 | tube morphogenesis | 1.04E-10 | 1.92E-8 | 2.81 (18547,263,1181,47) | 
GO:0007005 | mitochondrion organization | 1.24E-10 | 2.26E-8 | 2.66 (18547,301,1181,51) | 
GO:0048731 | system development | 1.53E-10 | 2.76E-8 | 2.02 (18547,693,1181,89) | 
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 2.08E-10 | 3.71E-8 | 3.56 (18547,141,1181,32) | 
GO:0048729 | tissue morphogenesis | 2.46E-10 | 4.34E-8 | 2.44 (18547,374,1181,58) | 
GO:0009058 | biosynthetic process | 2.87E-10 | 5.02E-8 | 1.47 (18547,2477,1181,232) | 
GO:0048878 | chemical homeostasis | 2.98E-10 | 5.14E-8 | 1.78 (18547,1058,1181,120) | 
GO:0090407 | organophosphate biosynthetic process | 4.38E-10 | 7.48E-8 | 2.14 (18547,544,1181,74) | 
GO:0070085 | glycosylation | 4.55E-10 | 7.68E-8 | 2.80 (18547,247,1181,44) | 
GO:0006754 | ATP biosynthetic process | 4.96E-10 | 8.28E-8 | 4.92 (18547,67,1181,21) | 
GO:0009199 | ribonucleoside triphosphate metabolic process | 6.44E-10 | 1.06E-7 | 3.42 (18547,147,1181,32) | 
GO:0042592 | homeostatic process | 7.48E-10 | 1.22E-7 | 1.62 (18547,1490,1181,154) | 
GO:0009144 | purine nucleoside triphosphate metabolic process | 7.73E-10 | 1.25E-7 | 3.40 (18547,148,1181,32) | 
GO:0055114 | oxidation-reduction process | 8.68E-10 | 1.39E-7 | 1.84 (18547,888,1181,104) | 
GO:0099111 | microtubule-based transport | 9.25E-10 | 1.47E-7 | 3.37 (18547,149,1181,32) | 
GO:0010970 | transport along microtubule | 9.25E-10 | 1.45E-7 | 3.37 (18547,149,1181,32) | 
GO:0048869 | cellular developmental process | 1.08E-9 | 1.69E-7 | 1.43 (18547,2701,1181,246) | 
GO:0098656 | anion transmembrane transport | 1.15E-9 | 1.78E-7 | 2.76 (18547,245,1181,43) | 
GO:0035269 | protein O-linked mannosylation | 1.4E-9 | 2.13E-7 | 9.60 (18547,18,1181,11) | 
GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process | 2.36E-9 | 3.56E-7 | 10.47 (18547,15,1181,10) | 
GO:0015711 | organic anion transport | 2.89E-9 | 4.32E-7 | 2.25 (18547,419,1181,60) | 
GO:0097711 | ciliary basal body-plasma membrane docking | 3.88E-9 | 5.74E-7 | 3.97 (18547,95,1181,24) | 
GO:0001654 | eye development | 4.01E-9 | 5.88E-7 | 4.10 (18547,88,1181,23) | 
GO:0071702 | organic substance transport | 4.25E-9 | 6.17E-7 | 1.49 (18547,2031,1181,193) | 
GO:0051640 | organelle localization | 4.97E-9 | 7.14E-7 | 2.12 (18547,488,1181,66) | 
GO:0002009 | morphogenesis of an epithelium | 5.92E-9 | 8.44E-7 | 2.55 (18547,277,1181,45) | 
GO:0006082 | organic acid metabolic process | 6.56E-9 | 9.26E-7 | 1.74 (18547,981,1181,109) | 
GO:0043436 | oxoacid metabolic process | 7.71E-9 | 1.08E-6 | 1.75 (18547,960,1181,107) | 
GO:0022900 | electron transport chain | 8.2E-9 | 1.14E-6 | 3.10 (18547,162,1181,32) | 
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 8.27E-9 | 1.14E-6 | 4.28 (18547,77,1181,21) | 
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 1.06E-8 | 1.44E-6 | 12.56 (18547,10,1181,8) | 
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1.06E-8 | 1.44E-6 | 4.23 (18547,78,1181,21) | 
GO:0140056 | organelle localization by membrane tethering | 1.31E-8 | 1.75E-6 | 3.05 (18547,165,1181,32) | 
GO:0022406 | membrane docking | 1.39E-8 | 1.84E-6 | 2.98 (18547,174,1181,33) | 
GO:0048468 | cell development | 1.57E-8 | 2.07E-6 | 1.92 (18547,646,1181,79) | 
GO:0051649 | establishment of localization in cell | 1.65E-8 | 2.16E-6 | 1.53 (18547,1687,1181,164) | 
GO:0060632 | regulation of microtubule-based movement | 1.76E-8 | 2.28E-6 | 7.25 (18547,26,1181,12) | 
GO:0006928 | movement of cell or subcellular component | 1.78E-8 | 2.29E-6 | 1.60 (18547,1357,1181,138) | 
GO:0007423 | sensory organ development | 1.96E-8 | 2.5E-6 | 3.46 (18547,118,1181,26) | 
GO:0017144 | drug metabolic process | 1.98E-8 | 2.5E-6 | 1.98 (18547,571,1181,72) | 
GO:0030705 | cytoskeleton-dependent intracellular transport | 2.05E-8 | 2.57E-6 | 2.99 (18547,168,1181,32) | 
GO:0009141 | nucleoside triphosphate metabolic process | 2.05E-8 | 2.55E-6 | 2.99 (18547,168,1181,32) | 
GO:0006488 | dolichol-linked oligosaccharide biosynthetic process | 2.5E-8 | 3.08E-6 | 10.10 (18547,14,1181,9) | 
GO:0050801 | ion homeostasis | 2.62E-8 | 3.2E-6 | 1.83 (18547,757,1181,88) | 
GO:0098771 | inorganic ion homeostasis | 3.02E-8 | 3.66E-6 | 1.87 (18547,690,1181,82) | 
GO:0055067 | monovalent inorganic cation homeostasis | 3.22E-8 | 3.88E-6 | 3.21 (18547,137,1181,28) | 
GO:0030001 | metal ion transport | 3.35E-8 | 4.01E-6 | 1.92 (18547,612,1181,75) | 
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 3.52E-8 | 4.17E-6 | 3.97 (18547,83,1181,21) | 
GO:0016558 | protein import into peroxisome matrix | 3.67E-8 | 4.32E-6 | 11.42 (18547,11,1181,8) | 
GO:0003356 | regulation of cilium beat frequency | 3.67E-8 | 4.28E-6 | 11.42 (18547,11,1181,8) | 
GO:0035721 | intraciliary retrograde transport | 3.67E-8 | 4.25E-6 | 11.42 (18547,11,1181,8) | 
GO:0007600 | sensory perception | 4.16E-8 | 4.78E-6 | 1.98 (18547,548,1181,69) | 
GO:0009167 | purine ribonucleoside monophosphate metabolic process | 4.19E-8 | 4.79E-6 | 3.10 (18547,147,1181,29) | 
GO:0003351 | epithelial cilium movement | 4.42E-8 | 5.02E-6 | 7.51 (18547,23,1181,11) | 
GO:0009126 | purine nucleoside monophosphate metabolic process | 4.9E-8 | 5.52E-6 | 3.08 (18547,148,1181,29) | 
GO:0042073 | intraciliary transport | 5.67E-8 | 6.34E-6 | 4.93 (18547,51,1181,16) | 
GO:0044249 | cellular biosynthetic process | 5.75E-8 | 6.39E-6 | 1.42 (18547,2289,1181,207) | 
GO:0015919 | peroxisomal membrane transport | 5.89E-8 | 6.49E-6 | 9.42 (18547,15,1181,9) | 
GO:0055080 | cation homeostasis | 6.49E-8 | 7.1E-6 | 1.85 (18547,679,1181,80) | 
GO:0009150 | purine ribonucleotide metabolic process | 6.68E-8 | 7.26E-6 | 2.26 (18547,340,1181,49) | 
GO:0010257 | NADH dehydrogenase complex assembly | 6.77E-8 | 7.31E-6 | 4.60 (18547,58,1181,17) | 
GO:0032981 | mitochondrial respiratory chain complex I assembly | 6.77E-8 | 7.26E-6 | 4.60 (18547,58,1181,17) | 
GO:0035268 | protein mannosylation | 7.7E-8 | 8.19E-6 | 7.20 (18547,24,1181,11) | 
GO:0035735 | intraciliary transport involved in cilium assembly | 8.09E-8 | 8.55E-6 | 5.50 (18547,40,1181,14) | 
GO:0065008 | regulation of biological quality | 8.14E-8 | 8.54E-6 | 1.31 (18547,3617,1181,302) | 
GO:0015893 | drug transport | 9.01E-8 | 9.4E-6 | 3.00 (18547,152,1181,29) | 
GO:0007006 | mitochondrial membrane organization | 9.89E-8 | 1.02E-5 | 3.30 (18547,119,1181,25) | 
GO:0006486 | protein glycosylation | 1.13E-7 | 1.17E-5 | 2.53 (18547,236,1181,38) | 
GO:0043413 | macromolecule glycosylation | 1.13E-7 | 1.16E-5 | 2.53 (18547,236,1181,38) | 
GO:0043039 | tRNA aminoacylation | 1.14E-7 | 1.16E-5 | 5.01 (18547,47,1181,15) | 
GO:0043933 | protein-containing complex subunit organization | 1.26E-7 | 1.28E-5 | 1.48 (18547,1765,1181,166) | 
GO:0046467 | membrane lipid biosynthetic process | 1.39E-7 | 1.4E-5 | 3.24 (18547,121,1181,25) | 
GO:0071705 | nitrogen compound transport | 1.4E-7 | 1.39E-5 | 1.49 (18547,1689,1181,160) | 
GO:0006643 | membrane lipid metabolic process | 1.43E-7 | 1.41E-5 | 2.71 (18547,191,1181,33) | 
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.48E-7 | 1.46E-5 | 1.81 (18547,704,1181,81) | 
GO:0043473 | pigmentation | 1.54E-7 | 1.51E-5 | 5.67 (18547,36,1181,13) | 
GO:0043038 | amino acid activation | 1.56E-7 | 1.52E-5 | 4.91 (18547,48,1181,15) | 
GO:0019752 | carboxylic acid metabolic process | 1.65E-7 | 1.59E-5 | 1.71 (18547,872,1181,95) | 
GO:0009127 | purine nucleoside monophosphate biosynthetic process | 1.94E-7 | 1.86E-5 | 3.62 (18547,91,1181,21) | 
GO:0009168 | purine ribonucleoside monophosphate biosynthetic process | 1.94E-7 | 1.85E-5 | 3.62 (18547,91,1181,21) | 
GO:0043062 | extracellular structure organization | 1.98E-7 | 1.87E-5 | 2.15 (18547,373,1181,51) | 
GO:0003143 | embryonic heart tube morphogenesis | 1.99E-7 | 1.87E-5 | 4.31 (18547,62,1181,17) | 
GO:0001501 | skeletal system development | 2.18E-7 | 2.04E-5 | 2.82 (18547,167,1181,30) | 
GO:0008589 | regulation of smoothened signaling pathway | 2.4E-7 | 2.23E-5 | 3.88 (18547,77,1181,19) | 
GO:0001947 | heart looping | 2.43E-7 | 2.25E-5 | 4.49 (18547,56,1181,16) | 
GO:0006664 | glycolipid metabolic process | 2.45E-7 | 2.25E-5 | 3.45 (18547,100,1181,22) | 
GO:0009152 | purine ribonucleotide biosynthetic process | 2.48E-7 | 2.26E-5 | 2.75 (18547,177,1181,31) | 
GO:0009259 | ribonucleotide metabolic process | 2.57E-7 | 2.33E-5 | 2.17 (18547,355,1181,49) | 
GO:0009161 | ribonucleoside monophosphate metabolic process | 2.84E-7 | 2.56E-5 | 2.85 (18547,160,1181,29) | 
GO:0099131 | ATP hydrolysis coupled ion transmembrane transport | 2.88E-7 | 2.59E-5 | 5.89 (18547,32,1181,12) | 
GO:1903509 | liposaccharide metabolic process | 2.95E-7 | 2.63E-5 | 3.42 (18547,101,1181,22) | 
GO:0006418 | tRNA aminoacylation for protein translation | 3.15E-7 | 2.8E-5 | 5.00 (18547,44,1181,14) | 
GO:0046907 | intracellular transport | 3.19E-7 | 2.81E-5 | 1.52 (18547,1450,1181,140) | 
GO:0009142 | nucleoside triphosphate biosynthetic process | 3.48E-7 | 3.06E-5 | 3.51 (18547,94,1181,21) | 
GO:0055065 | metal ion homeostasis | 3.48E-7 | 3.04E-5 | 1.85 (18547,602,1181,71) | 
GO:0006163 | purine nucleotide metabolic process | 3.61E-7 | 3.13E-5 | 2.14 (18547,359,1181,49) | 
GO:0034622 | cellular protein-containing complex assembly | 4.13E-7 | 3.57E-5 | 1.72 (18547,793,1181,87) | 
GO:0015849 | organic acid transport | 4.2E-7 | 3.6E-5 | 2.32 (18547,278,1181,41) | 
GO:0046942 | carboxylic acid transport | 4.2E-7 | 3.58E-5 | 2.32 (18547,278,1181,41) | 
GO:0090662 | ATP hydrolysis coupled transmembrane transport | 4.26E-7 | 3.62E-5 | 5.71 (18547,33,1181,12) | 
GO:0008544 | epidermis development | 4.57E-7 | 3.85E-5 | 3.73 (18547,80,1181,19) | 
GO:0019693 | ribose phosphate metabolic process | 5.19E-7 | 4.36E-5 | 2.10 (18547,374,1181,50) | 
GO:0019725 | cellular homeostasis | 5.28E-7 | 4.41E-5 | 1.68 (18547,858,1181,92) | 
GO:0036159 | inner dynein arm assembly | 5.61E-7 | 4.66E-5 | 8.97 (18547,14,1181,8) | 
GO:0030326 | embryonic limb morphogenesis | 5.61E-7 | 4.64E-5 | 3.68 (18547,81,1181,19) | 
GO:0035113 | embryonic appendage morphogenesis | 5.61E-7 | 4.61E-5 | 3.68 (18547,81,1181,19) | 
GO:0032400 | melanosome localization | 5.62E-7 | 4.6E-5 | 6.83 (18547,23,1181,10) | 
GO:0044458 | motile cilium assembly | 5.62E-7 | 4.57E-5 | 6.83 (18547,23,1181,10) | 
GO:0006164 | purine nucleotide biosynthetic process | 5.99E-7 | 4.84E-5 | 2.65 (18547,184,1181,31) | 
GO:0007031 | peroxisome organization | 6.24E-7 | 5.02E-5 | 3.82 (18547,74,1181,18) | 
GO:0001503 | ossification | 6.81E-7 | 5.45E-5 | 3.17 (18547,114,1181,23) | 
GO:0060562 | epithelial tube morphogenesis | 7.28E-7 | 5.8E-5 | 3.37 (18547,98,1181,21) | 
GO:0055075 | potassium ion homeostasis | 7.93E-7 | 6.29E-5 | 5.96 (18547,29,1181,11) | 
GO:0055082 | cellular chemical homeostasis | 8.15E-7 | 6.42E-5 | 1.75 (18547,698,1181,78) | 
GO:0008654 | phospholipid biosynthetic process | 8.39E-7 | 6.59E-5 | 2.41 (18547,235,1181,36) | 
GO:0043574 | peroxisomal transport | 8.4E-7 | 6.56E-5 | 3.93 (18547,68,1181,17) | 
GO:0030198 | extracellular matrix organization | 8.55E-7 | 6.64E-5 | 2.16 (18547,327,1181,45) | 
GO:0065003 | protein-containing complex assembly | 9.08E-7 | 7.01E-5 | 1.49 (18547,1490,1181,141) | 
GO:0051875 | pigment granule localization | 9.08E-7 | 6.99E-5 | 6.54 (18547,24,1181,10) | 
GO:0090131 | mesenchyme migration | 1.04E-6 | 7.95E-5 | 15.70 (18547,5,1181,5) | 
GO:0045017 | glycerolipid biosynthetic process | 1.07E-6 | 8.17E-5 | 2.49 (18547,208,1181,33) | 
GO:0015991 | ATP hydrolysis coupled proton transport | 1.18E-6 | 8.95E-5 | 5.76 (18547,30,1181,11) | 
GO:0006644 | phospholipid metabolic process | 1.2E-6 | 9.06E-5 | 2.08 (18547,363,1181,48) | 
GO:0009260 | ribonucleotide biosynthetic process | 1.22E-6 | 9.18E-5 | 2.56 (18547,190,1181,31) | 
GO:0072521 | purine-containing compound metabolic process | 1.25E-6 | 9.32E-5 | 2.02 (18547,396,1181,51) | 
GO:0009123 | nucleoside monophosphate metabolic process | 1.29E-6 | 9.59E-5 | 2.60 (18547,181,1181,30) | 
GO:0006505 | GPI anchor metabolic process | 1.43E-6 | 1.06E-4 | 6.28 (18547,25,1181,10) | 
GO:0055076 | transition metal ion homeostasis | 1.58E-6 | 1.16E-4 | 2.94 (18547,128,1181,24) | 
GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient | 1.73E-6 | 1.26E-4 | 5.57 (18547,31,1181,11) | 
GO:0007610 | behavior | 1.9E-6 | 1.38E-4 | 1.82 (18547,560,1181,65) | 
GO:0008104 | protein localization | 1.95E-6 | 1.42E-4 | 1.41 (18547,1843,1181,166) | 
GO:1901566 | organonitrogen compound biosynthetic process | 2.01E-6 | 1.45E-4 | 1.61 (18547,947,1181,97) | 
GO:0009156 | ribonucleoside monophosphate biosynthetic process | 2.03E-6 | 1.46E-4 | 3.17 (18547,104,1181,21) | 
GO:0035107 | appendage morphogenesis | 2.12E-6 | 1.52E-4 | 3.27 (18547,96,1181,20) | 
GO:0035108 | limb morphogenesis | 2.12E-6 | 1.51E-4 | 3.27 (18547,96,1181,20) | 
GO:0035725 | sodium ion transmembrane transport | 2.16E-6 | 1.53E-4 | 3.39 (18547,88,1181,19) | 
GO:0043010 | camera-type eye development | 2.33E-6 | 1.64E-4 | 4.06 (18547,58,1181,15) | 
GO:0009953 | dorsal/ventral pattern formation | 2.33E-6 | 1.64E-4 | 4.31 (18547,51,1181,14) | 
GO:0006493 | protein O-linked glycosylation | 2.39E-6 | 1.67E-4 | 3.14 (18547,105,1181,21) | 
GO:0046390 | ribose phosphate biosynthetic process | 2.41E-6 | 1.68E-4 | 2.48 (18547,196,1181,31) | 
GO:0033036 | macromolecule localization | 2.41E-6 | 1.67E-4 | 1.41 (18547,1863,1181,167) | 
GO:0044743 | protein transmembrane import into intracellular organelle | 2.42E-6 | 1.67E-4 | 4.96 (18547,38,1181,12) | 
GO:0006814 | sodium ion transport | 2.42E-6 | 1.67E-4 | 2.74 (18547,149,1181,26) | 
GO:0032402 | melanosome transport | 2.44E-6 | 1.67E-4 | 6.73 (18547,21,1181,9) | 
GO:0006399 | tRNA metabolic process | 2.59E-6 | 1.76E-4 | 2.52 (18547,187,1181,30) | 
GO:0072522 | purine-containing compound biosynthetic process | 2.69E-6 | 1.82E-4 | 2.47 (18547,197,1181,31) | 
GO:0046486 | glycerolipid metabolic process | 2.79E-6 | 1.89E-4 | 2.03 (18547,363,1181,47) | 
GO:0006855 | drug transmembrane transport | 2.98E-6 | 2.01E-4 | 3.61 (18547,74,1181,17) | 
GO:0042391 | regulation of membrane potential | 3.2E-6 | 2.14E-4 | 1.94 (18547,420,1181,52) | 
GO:0021983 | pituitary gland development | 3.28E-6 | 2.18E-4 | 5.82 (18547,27,1181,10) | 
GO:0006625 | protein targeting to peroxisome | 3.38E-6 | 2.24E-4 | 3.75 (18547,67,1181,16) | 
GO:0072663 | establishment of protein localization to peroxisome | 3.38E-6 | 2.23E-4 | 3.75 (18547,67,1181,16) | 
GO:0072662 | protein localization to peroxisome | 3.38E-6 | 2.22E-4 | 3.75 (18547,67,1181,16) | 
GO:0009124 | nucleoside monophosphate biosynthetic process | 3.49E-6 | 2.29E-4 | 2.98 (18547,116,1181,22) | 
GO:0046916 | cellular transition metal ion homeostasis | 3.5E-6 | 2.29E-4 | 3.17 (18547,99,1181,20) | 
GO:0032401 | establishment of melanosome localization | 3.9E-6 | 2.53E-4 | 6.42 (18547,22,1181,9) | 
GO:0051904 | pigment granule transport | 3.9E-6 | 2.52E-4 | 6.42 (18547,22,1181,9) | 
GO:0034551 | mitochondrial respiratory chain complex III assembly | 4.68E-6 | 3.02E-4 | 10.47 (18547,9,1181,6) | 
GO:0017062 | respiratory chain complex III assembly | 4.68E-6 | 3E-4 | 10.47 (18547,9,1181,6) | 
GO:1903825 | organic acid transmembrane transport | 5.39E-6 | 3.45E-4 | 2.90 (18547,119,1181,22) | 
GO:1905039 | carboxylic acid transmembrane transport | 5.39E-6 | 3.43E-4 | 2.90 (18547,119,1181,22) | 
GO:0006506 | GPI anchor biosynthetic process | 6.04E-6 | 3.83E-4 | 6.15 (18547,23,1181,9) | 
GO:0051905 | establishment of pigment granule localization | 6.04E-6 | 3.81E-4 | 6.15 (18547,23,1181,9) | 
GO:0009247 | glycolipid biosynthetic process | 6.17E-6 | 3.88E-4 | 4.00 (18547,55,1181,14) | 
GO:0048562 | embryonic organ morphogenesis | 6.21E-6 | 3.89E-4 | 2.88 (18547,120,1181,22) | 
GO:0030324 | lung development | 6.4E-6 | 3.99E-4 | 3.42 (18547,78,1181,17) | 
GO:0044237 | cellular metabolic process | 7.72E-6 | 4.8E-4 | 1.15 (18547,7315,1181,537) | 
GO:0065002 | intracellular protein transmembrane transport | 7.75E-6 | 4.8E-4 | 3.93 (18547,56,1181,14) | 
GO:0043588 | skin development | 9.11E-6 | 5.62E-4 | 4.80 (18547,36,1181,11) | 
GO:0030318 | melanocyte differentiation | 1.06E-5 | 6.51E-4 | 6.61 (18547,19,1181,8) | 
GO:0050931 | pigment cell differentiation | 1.06E-5 | 6.48E-4 | 6.61 (18547,19,1181,8) | 
GO:0071806 | protein transmembrane transport | 1.07E-5 | 6.49E-4 | 3.62 (18547,65,1181,15) | 
GO:0006650 | glycerophospholipid metabolic process | 1.09E-5 | 6.62E-4 | 2.08 (18547,294,1181,39) | 
GO:0006936 | muscle contraction | 1.13E-5 | 6.86E-4 | 2.31 (18547,211,1181,31) | 
GO:0006873 | cellular ion homeostasis | 1.2E-5 | 7.22E-4 | 1.71 (18547,616,1181,67) | 
GO:0006672 | ceramide metabolic process | 1.3E-5 | 7.79E-4 | 3.26 (18547,82,1181,17) | 
GO:0099587 | inorganic ion import across plasma membrane | 1.33E-5 | 7.92E-4 | 3.40 (18547,74,1181,16) | 
GO:0098659 | inorganic cation import across plasma membrane | 1.33E-5 | 7.89E-4 | 3.40 (18547,74,1181,16) | 
GO:0030154 | cell differentiation | 1.37E-5 | 8.13E-4 | 1.38 (18547,1824,1181,160) | 
GO:0030004 | cellular monovalent inorganic cation homeostasis | 1.39E-5 | 8.2E-4 | 2.91 (18547,108,1181,20) | 
GO:0009117 | nucleotide metabolic process | 1.44E-5 | 8.48E-4 | 1.80 (18547,489,1181,56) | 
GO:0003012 | muscle system process | 1.46E-5 | 8.53E-4 | 2.16 (18547,255,1181,35) | 
GO:1901617 | organic hydroxy compound biosynthetic process | 1.53E-5 | 8.95E-4 | 2.39 (18547,184,1181,28) | 
GO:0034553 | mitochondrial respiratory chain complex II assembly | 1.64E-5 | 9.52E-4 | 15.70 (18547,4,1181,4) | 
GO:0034552 | respiratory chain complex II assembly | 1.64E-5 | 9.48E-4 | 15.70 (18547,4,1181,4) | 
GO:0006121 | mitochondrial electron transport, succinate to ubiquinone | 1.64E-5 | 9.45E-4 | 15.70 (18547,4,1181,4) | 
GO:0048854 | brain morphogenesis | 1.67E-5 | 9.59E-4 | 6.28 (18547,20,1181,8) | 
GO:0046474 | glycerophospholipid biosynthetic process | 1.88E-5 | 1.08E-3 | 2.32 (18547,196,1181,29) | 
GO:0009165 | nucleotide biosynthetic process | 1.94E-5 | 1.11E-3 | 2.10 (18547,269,1181,36) | 
GO:0071907 | determination of digestive tract left/right asymmetry | 1.96E-5 | 1.11E-3 | 11.22 (18547,7,1181,5) | 
GO:0098739 | import across plasma membrane | 1.98E-5 | 1.12E-3 | 3.04 (18547,93,1181,18) | 
GO:0046513 | ceramide biosynthetic process | 2.16E-5 | 1.22E-3 | 4.10 (18547,46,1181,12) | 
GO:0006753 | nucleoside phosphate metabolic process | 2.17E-5 | 1.22E-3 | 1.77 (18547,496,1181,56) | 
GO:0051648 | vesicle localization | 2.39E-5 | 1.34E-3 | 2.73 (18547,121,1181,21) | 
GO:1901615 | organic hydroxy compound metabolic process | 2.58E-5 | 1.44E-3 | 1.83 (18547,429,1181,50) | 
GO:1901293 | nucleoside phosphate biosynthetic process | 2.67E-5 | 1.49E-3 | 2.07 (18547,273,1181,36) | 
GO:0051181 | cofactor transport | 2.73E-5 | 1.52E-3 | 4.01 (18547,47,1181,12) | 
GO:0042481 | regulation of odontogenesis | 2.75E-5 | 1.52E-3 | 5.23 (18547,27,1181,9) | 
GO:0006865 | amino acid transport | 2.77E-5 | 1.52E-3 | 2.78 (18547,113,1181,20) | 
GO:0006744 | ubiquinone biosynthetic process | 2.86E-5 | 1.57E-3 | 6.87 (18547,16,1181,7) | 
GO:1901663 | quinone biosynthetic process | 2.86E-5 | 1.57E-3 | 6.87 (18547,16,1181,7) | 
GO:0001508 | action potential | 3.15E-5 | 1.71E-3 | 3.18 (18547,79,1181,16) | 
GO:0010107 | potassium ion import | 3.57E-5 | 1.94E-3 | 4.21 (18547,41,1181,11) | 
GO:1990573 | potassium ion import across plasma membrane | 3.57E-5 | 1.93E-3 | 4.21 (18547,41,1181,11) | 
GO:0007507 | heart development | 3.74E-5 | 2.02E-3 | 2.28 (18547,193,1181,28) | 
GO:0030003 | cellular cation homeostasis | 4.17E-5 | 2.24E-3 | 1.66 (18547,604,1181,64) | 
GO:1990403 | embryonic brain development | 4.36E-5 | 2.33E-3 | 7.85 (18547,12,1181,6) | 
GO:0006743 | ubiquinone metabolic process | 4.6E-5 | 2.46E-3 | 6.47 (18547,17,1181,7) | 
GO:1901264 | carbohydrate derivative transport | 4.75E-5 | 2.53E-3 | 3.38 (18547,65,1181,14) | 
GO:0090130 | tissue migration | 4.94E-5 | 2.62E-3 | 9.82 (18547,8,1181,5) | 
GO:0050890 | cognition | 4.97E-5 | 2.62E-3 | 1.99 (18547,292,1181,37) | 
GO:0001822 | kidney development | 5.03E-5 | 2.65E-3 | 2.60 (18547,127,1181,21) | 
GO:0055072 | iron ion homeostasis | 5.08E-5 | 2.67E-3 | 3.06 (18547,82,1181,16) | 
GO:0042181 | ketone biosynthetic process | 5.23E-5 | 2.73E-3 | 4.87 (18547,29,1181,9) | 
GO:0032886 | regulation of microtubule-based process | 5.26E-5 | 2.74E-3 | 2.20 (18547,207,1181,29) | 
GO:0001764 | neuron migration | 5.26E-5 | 2.73E-3 | 2.66 (18547,118,1181,20) | 
GO:0048754 | branching morphogenesis of an epithelial tube | 5.26E-5 | 2.72E-3 | 2.66 (18547,118,1181,20) | 
GO:0005975 | carbohydrate metabolic process | 5.69E-5 | 2.94E-3 | 1.76 (18547,454,1181,51) | 
GO:0061512 | protein localization to cilium | 5.78E-5 | 2.97E-3 | 4.02 (18547,43,1181,11) | 
GO:0051180 | vitamin transport | 5.83E-5 | 2.99E-3 | 4.36 (18547,36,1181,10) | 
GO:0061138 | morphogenesis of a branching epithelium | 5.96E-5 | 3.05E-3 | 2.50 (18547,138,1181,22) | 
GO:0048705 | skeletal system morphogenesis | 6.15E-5 | 3.13E-3 | 2.71 (18547,110,1181,19) | 
GO:0008152 | metabolic process | 6.31E-5 | 3.2E-3 | 1.12 (18547,8089,1181,579) | 
GO:0055086 | nucleobase-containing small molecule metabolic process | 6.38E-5 | 3.23E-3 | 1.66 (18547,576,1181,61) | 
GO:0009798 | axis specification | 6.77E-5 | 3.41E-3 | 3.28 (18547,67,1181,14) | 
GO:0006879 | cellular iron ion homeostasis | 6.85E-5 | 3.44E-3 | 3.46 (18547,59,1181,13) | 
GO:0048747 | muscle fiber development | 6.85E-5 | 3.43E-3 | 3.46 (18547,59,1181,13) | 
GO:0051650 | establishment of vesicle localization | 6.99E-5 | 3.49E-3 | 2.69 (18547,111,1181,19) | 
GO:0086010 | membrane depolarization during action potential | 7.05E-5 | 3.51E-3 | 4.71 (18547,30,1181,9) | 
GO:0043113 | receptor clustering | 7.26E-5 | 3.61E-3 | 3.93 (18547,44,1181,11) | 
GO:0001701 | in utero embryonic development | 7.63E-5 | 3.78E-3 | 2.31 (18547,170,1181,25) | 
GO:0032438 | melanosome organization | 7.74E-5 | 3.82E-3 | 5.23 (18547,24,1181,8) | 
GO:0048741 | skeletal muscle fiber development | 7.74E-5 | 3.81E-3 | 5.23 (18547,24,1181,8) | 
GO:0030203 | glycosaminoglycan metabolic process | 8.44E-5 | 4.14E-3 | 2.39 (18547,151,1181,23) | 
GO:0030199 | collagen fibril organization | 9.07E-5 | 4.43E-3 | 3.84 (18547,45,1181,11) | 
GO:0043009 | chordate embryonic development | 9.26E-5 | 4.51E-3 | 2.28 (18547,172,1181,25) | 
GO:0015698 | inorganic anion transport | 9.36E-5 | 4.54E-3 | 2.38 (18547,152,1181,23) | 
GO:0006520 | cellular amino acid metabolic process | 9.95E-5 | 4.82E-3 | 1.91 (18547,313,1181,38) | 
GO:0007420 | brain development | 1.01E-4 | 4.87E-3 | 2.16 (18547,204,1181,28) | 
GO:1901362 | organic cyclic compound biosynthetic process | 1.04E-4 | 5.01E-3 | 1.41 (18547,1283,1181,115) | 
GO:0098661 | inorganic anion transmembrane transport | 1.05E-4 | 5.05E-3 | 2.69 (18547,105,1181,18) | 
GO:0015886 | heme transport | 1.05E-4 | 5.04E-3 | 8.72 (18547,9,1181,5) | 
GO:0048753 | pigment granule organization | 1.08E-4 | 5.12E-3 | 5.03 (18547,25,1181,8) | 
GO:0032787 | monocarboxylic acid metabolic process | 1.3E-4 | 6.15E-3 | 1.69 (18547,493,1181,53) | 
GO:0048589 | developmental growth | 1.35E-4 | 6.4E-3 | 1.92 (18547,295,1181,36) | 
GO:0050891 | multicellular organismal water homeostasis | 1.4E-4 | 6.6E-3 | 3.24 (18547,63,1181,13) | 
GO:0030148 | sphingolipid biosynthetic process | 1.41E-4 | 6.65E-3 | 2.82 (18547,89,1181,16) | 
GO:0055083 | monovalent inorganic anion homeostasis | 1.47E-4 | 6.88E-3 | 4.83 (18547,26,1181,8) | 
GO:0001763 | morphogenesis of a branching structure | 1.55E-4 | 7.26E-3 | 2.35 (18547,147,1181,22) | 
GO:0002088 | lens development in camera-type eye | 1.6E-4 | 7.45E-3 | 4.28 (18547,33,1181,9) | 
GO:0035115 | embryonic forelimb morphogenesis | 1.6E-4 | 7.43E-3 | 4.28 (18547,33,1181,9) | 
GO:0048704 | embryonic skeletal system morphogenesis | 1.6E-4 | 7.44E-3 | 2.91 (18547,81,1181,15) | 
GO:0030641 | regulation of cellular pH | 1.62E-4 | 7.48E-3 | 2.79 (18547,90,1181,16) | 
GO:0055081 | anion homeostasis | 1.72E-4 | 7.92E-3 | 3.37 (18547,56,1181,12) | 
GO:0034613 | cellular protein localization | 1.88E-4 | 8.65E-3 | 1.45 (18547,996,1181,92) | 
GO:0035136 | forelimb morphogenesis | 1.92E-4 | 8.81E-3 | 3.83 (18547,41,1181,10) | 
GO:0014904 | myotube cell development | 1.97E-4 | 8.99E-3 | 4.65 (18547,27,1181,8) | 
GO:0042487 | regulation of odontogenesis of dentin-containing tooth | 2E-4 | 9.11E-3 | 6.28 (18547,15,1181,6) | 
GO:0015807 | L-amino acid transport | 2.05E-4 | 9.32E-3 | 3.31 (18547,57,1181,12) | 
GO:0042472 | inner ear morphogenesis | 2.05E-4 | 9.29E-3 | 3.31 (18547,57,1181,12) | 
GO:0006665 | sphingolipid metabolic process | 2.09E-4 | 9.43E-3 | 2.30 (18547,150,1181,22) | 
GO:0048514 | blood vessel morphogenesis | 2.13E-4 | 9.58E-3 | 2.84 (18547,83,1181,15) | 
GO:0002063 | chondrocyte development | 2.2E-4 | 9.86E-3 | 5.23 (18547,21,1181,7) | 
GO:0008611 | ether lipid biosynthetic process | 2.21E-4 | 9.9E-3 | 10.47 (18547,6,1181,4) | 
GO:1901503 | ether biosynthetic process | 2.21E-4 | 9.87E-3 | 10.47 (18547,6,1181,4) | 
GO:0021540 | corpus callosum morphogenesis | 2.21E-4 | 9.84E-3 | 10.47 (18547,6,1181,4) | 
GO:0046504 | glycerol ether biosynthetic process | 2.21E-4 | 9.82E-3 | 10.47 (18547,6,1181,4) | 
GO:0006022 | aminoglycan metabolic process | 2.25E-4 | 9.97E-3 | 2.24 (18547,161,1181,23) | 
GO:0040007 | growth | 2.3E-4 | 1.02E-2 | 1.87 (18547,303,1181,36) | 
GO:0006836 | neurotransmitter transport | 2.31E-4 | 1.02E-2 | 2.40 (18547,131,1181,20) | 
GO:0060348 | bone development | 2.38E-4 | 1.04E-2 | 3.74 (18547,42,1181,10) | 
GO:0051453 | regulation of intracellular pH | 2.44E-4 | 1.07E-2 | 2.80 (18547,84,1181,15) | 
GO:0009952 | anterior/posterior pattern specification | 2.53E-4 | 1.1E-2 | 2.27 (18547,152,1181,22) | 
GO:0070727 | cellular macromolecule localization | 2.56E-4 | 1.11E-2 | 1.44 (18547,1005,1181,92) | 
GO:0000379 | tRNA-type intron splice site recognition and cleavage | 2.58E-4 | 1.12E-2 | 15.70 (18547,3,1181,3) | 
GO:0031120 | snRNA pseudouridine synthesis | 2.58E-4 | 1.11E-2 | 15.70 (18547,3,1181,3) | 
GO:0090427 | activation of meiosis | 2.58E-4 | 1.11E-2 | 15.70 (18547,3,1181,3) | 
GO:0035880 | embryonic nail plate morphogenesis | 2.58E-4 | 1.11E-2 | 15.70 (18547,3,1181,3) | 
GO:0060536 | cartilage morphogenesis | 2.6E-4 | 1.12E-2 | 4.49 (18547,28,1181,8) | 
GO:0030104 | water homeostasis | 2.67E-4 | 1.14E-2 | 3.05 (18547,67,1181,13) | 
GO:0006497 | protein lipidation | 2.78E-4 | 1.19E-2 | 2.89 (18547,76,1181,14) | 
GO:0006767 | water-soluble vitamin metabolic process | 2.79E-4 | 1.19E-2 | 2.77 (18547,85,1181,15) | 
GO:0001658 | branching involved in ureteric bud morphogenesis | 2.93E-4 | 1.24E-2 | 3.65 (18547,43,1181,10) | 
GO:0072348 | sulfur compound transport | 2.93E-4 | 1.24E-2 | 3.65 (18547,43,1181,10) | 
GO:0033365 | protein localization to organelle | 2.94E-4 | 1.24E-2 | 1.56 (18547,634,1181,63) | 
GO:0060294 | cilium movement involved in cell motility | 3.03E-4 | 1.27E-2 | 5.89 (18547,16,1181,6) | 
GO:0007035 | vacuolar acidification | 3.04E-4 | 1.28E-2 | 5.00 (18547,22,1181,7) | 
GO:0060070 | canonical Wnt signaling pathway | 3.2E-4 | 1.34E-2 | 2.86 (18547,77,1181,14) | 
GO:0045494 | photoreceptor cell maintenance | 3.28E-4 | 1.37E-2 | 3.93 (18547,36,1181,9) | 
GO:0019228 | neuronal action potential | 3.4E-4 | 1.41E-2 | 4.33 (18547,29,1181,8) | 
GO:0035082 | axoneme assembly | 3.4E-4 | 1.41E-2 | 4.33 (18547,29,1181,8) | 
GO:0106074 | aminoacyl-tRNA metabolism involved in translational fidelity | 3.47E-4 | 1.44E-2 | 7.14 (18547,11,1181,5) | 
GO:0045995 | regulation of embryonic development | 3.48E-4 | 1.44E-2 | 2.39 (18547,125,1181,19) | 
GO:0031503 | protein-containing complex localization | 3.48E-4 | 1.43E-2 | 2.33 (18547,135,1181,20) | 
GO:0030182 | neuron differentiation | 3.61E-4 | 1.48E-2 | 1.95 (18547,242,1181,30) | 
GO:0007517 | muscle organ development | 3.69E-4 | 1.51E-2 | 2.52 (18547,106,1181,17) | 
GO:0006885 | regulation of pH | 3.93E-4 | 1.61E-2 | 2.59 (18547,97,1181,16) | 
GO:0035295 | tube development | 4.01E-4 | 1.64E-2 | 2.12 (18547,178,1181,24) | 
GO:0000959 | mitochondrial RNA metabolic process | 4.09E-4 | 1.66E-2 | 3.82 (18547,37,1181,9) | 
GO:0030509 | BMP signaling pathway | 4.12E-4 | 1.67E-2 | 2.68 (18547,88,1181,15) | 
GO:0006875 | cellular metal ion homeostasis | 4.3E-4 | 1.74E-2 | 1.60 (18547,530,1181,54) | 
GO:0061061 | muscle structure development | 4.62E-4 | 1.86E-2 | 2.47 (18547,108,1181,17) | 
GO:0045184 | establishment of protein localization | 4.77E-4 | 1.92E-2 | 1.35 (18547,1375,1181,118) | 
GO:0009790 | embryo development | 4.83E-4 | 1.94E-2 | 2.06 (18547,191,1181,25) | 
GO:0009792 | embryo development ending in birth or egg hatching | 4.83E-4 | 1.93E-2 | 2.06 (18547,191,1181,25) | 
GO:0044242 | cellular lipid catabolic process | 4.83E-4 | 1.93E-2 | 2.06 (18547,191,1181,25) | 
GO:0006771 | riboflavin metabolic process | 4.9E-4 | 1.95E-2 | 8.97 (18547,7,1181,4) | 
GO:0016042 | lipid catabolic process | 4.91E-4 | 1.95E-2 | 1.83 (18547,292,1181,34) | 
GO:0071704 | organic substance metabolic process | 4.99E-4 | 1.98E-2 | 1.11 (18547,7577,1181,537) | 
GO:0035148 | tube formation | 5.23E-4 | 2.07E-2 | 2.38 (18547,119,1181,18) | 
GO:0090103 | cochlea morphogenesis | 5.52E-4 | 2.18E-2 | 4.58 (18547,24,1181,7) | 
GO:0022404 | molting cycle process | 5.56E-4 | 2.19E-2 | 2.84 (18547,72,1181,13) | 
GO:0022405 | hair cycle process | 5.56E-4 | 2.18E-2 | 2.84 (18547,72,1181,13) | 
GO:0030278 | regulation of ossification | 5.57E-4 | 2.18E-2 | 2.07 (18547,182,1181,24) | 
GO:0032989 | cellular component morphogenesis | 5.58E-4 | 2.18E-2 | 1.65 (18547,437,1181,46) | 
GO:0006024 | glycosaminoglycan biosynthetic process | 5.58E-4 | 2.17E-2 | 2.51 (18547,100,1181,16) | 
GO:1901678 | iron coordination entity transport | 5.63E-4 | 2.19E-2 | 6.54 (18547,12,1181,5) | 
GO:0031581 | hemidesmosome assembly | 5.63E-4 | 2.18E-2 | 6.54 (18547,12,1181,5) | 
GO:0035751 | regulation of lysosomal lumen pH | 5.63E-4 | 2.18E-2 | 6.54 (18547,12,1181,5) | 
GO:0090287 | regulation of cellular response to growth factor stimulus | 5.71E-4 | 2.2E-2 | 1.87 (18547,260,1181,31) | 
GO:0007010 | cytoskeleton organization | 5.87E-4 | 2.26E-2 | 1.45 (18547,832,1181,77) | 
GO:0071805 | potassium ion transmembrane transport | 5.96E-4 | 2.29E-2 | 2.18 (18547,151,1181,21) | 
GO:0071804 | cellular potassium ion transport | 5.96E-4 | 2.28E-2 | 2.18 (18547,151,1181,21) | 
GO:0060429 | epithelium development | 6.17E-4 | 2.36E-2 | 2.23 (18547,141,1181,20) | 
GO:0045851 | pH reduction | 6.27E-4 | 2.39E-2 | 3.34 (18547,47,1181,10) | 
GO:0046148 | pigment biosynthetic process | 6.27E-4 | 2.38E-2 | 3.34 (18547,47,1181,10) | 
GO:0019432 | triglyceride biosynthetic process | 6.28E-4 | 2.38E-2 | 5.23 (18547,18,1181,6) | 
GO:0050878 | regulation of body fluid levels | 6.35E-4 | 2.4E-2 | 1.70 (18547,379,1181,41) | 
GO:1902652 | secondary alcohol metabolic process | 6.41E-4 | 2.42E-2 | 2.34 (18547,121,1181,18) | 
GO:0016125 | sterol metabolic process | 6.96E-4 | 2.62E-2 | 2.26 (18547,132,1181,19) | 
GO:0048701 | embryonic cranial skeleton morphogenesis | 7.02E-4 | 2.63E-2 | 3.93 (18547,32,1181,8) | 
GO:0007626 | locomotory behavior | 7.05E-4 | 2.64E-2 | 2.04 (18547,185,1181,24) | 
GO:0055002 | striated muscle cell development | 7.07E-4 | 2.64E-2 | 2.65 (18547,83,1181,14) | 
GO:0006766 | vitamin metabolic process | 7.08E-4 | 2.64E-2 | 2.32 (18547,122,1181,18) | 
GO:0070129 | regulation of mitochondrial translation | 7.25E-4 | 2.7E-2 | 4.40 (18547,25,1181,7) | 
GO:0044264 | cellular polysaccharide metabolic process | 7.29E-4 | 2.7E-2 | 2.76 (18547,74,1181,13) | 
GO:0006813 | potassium ion transport | 7.36E-4 | 2.72E-2 | 2.11 (18547,164,1181,22) | 
GO:0048666 | neuron development | 7.41E-4 | 2.73E-2 | 2.20 (18547,143,1181,20) | 
GO:0032330 | regulation of chondrocyte differentiation | 7.47E-4 | 2.75E-2 | 3.27 (18547,48,1181,10) | 
GO:0005977 | glycogen metabolic process | 7.47E-4 | 2.74E-2 | 3.27 (18547,48,1181,10) | 
GO:0055001 | muscle cell development | 7.53E-4 | 2.76E-2 | 2.53 (18547,93,1181,15) | 
GO:0061035 | regulation of cartilage development | 8.41E-4 | 3.07E-2 | 2.86 (18547,66,1181,12) | 
GO:0055064 | chloride ion homeostasis | 8.68E-4 | 3.16E-2 | 6.04 (18547,13,1181,5) | 
GO:0042438 | melanin biosynthetic process | 8.68E-4 | 3.16E-2 | 6.04 (18547,13,1181,5) | 
GO:0048667 | cell morphogenesis involved in neuron differentiation | 8.68E-4 | 3.15E-2 | 6.04 (18547,13,1181,5) | 
GO:0060349 | bone morphogenesis | 8.75E-4 | 3.17E-2 | 3.81 (18547,33,1181,8) | 
GO:0006073 | cellular glucan metabolic process | 8.86E-4 | 3.2E-2 | 3.20 (18547,49,1181,10) | 
GO:0044042 | glucan metabolic process | 8.86E-4 | 3.19E-2 | 3.20 (18547,49,1181,10) | 
GO:1901564 | organonitrogen compound metabolic process | 9.14E-4 | 3.29E-2 | 1.15 (18547,5099,1181,372) | 
GO:0042726 | flavin-containing compound metabolic process | 9.3E-4 | 3.34E-2 | 7.85 (18547,8,1181,4) | 
GO:0007042 | lysosomal lumen acidification | 9.3E-4 | 3.33E-2 | 7.85 (18547,8,1181,4) | 
GO:0021603 | cranial nerve formation | 9.3E-4 | 3.32E-2 | 7.85 (18547,8,1181,4) | 
GO:0097384 | cellular lipid biosynthetic process | 9.3E-4 | 3.32E-2 | 7.85 (18547,8,1181,4) | 
GO:0060075 | regulation of resting membrane potential | 9.3E-4 | 3.31E-2 | 7.85 (18547,8,1181,4) | 
GO:0017185 | peptidyl-lysine hydroxylation | 9.3E-4 | 3.3E-2 | 7.85 (18547,8,1181,4) | 
GO:0090092 | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 9.31E-4 | 3.29E-2 | 1.91 (18547,222,1181,27) | 
GO:0030206 | chondroitin sulfate biosynthetic process | 9.38E-4 | 3.31E-2 | 4.23 (18547,26,1181,7) | 
GO:0001958 | endochondral ossification | 9.38E-4 | 3.31E-2 | 4.23 (18547,26,1181,7) | 
GO:0036075 | replacement ossification | 9.38E-4 | 3.3E-2 | 4.23 (18547,26,1181,7) | 
GO:0006023 | aminoglycan biosynthetic process | 9.63E-4 | 3.38E-2 | 2.39 (18547,105,1181,16) | 
GO:0061024 | membrane organization | 9.78E-4 | 3.42E-2 | 1.49 (18547,664,1181,63) | 
GO:0032218 | riboflavin transport | 9.81E-4 | 3.43E-2 | 11.78 (18547,4,1181,3) | 
GO:0071934 | thiamine transmembrane transport | 9.81E-4 | 3.42E-2 | 11.78 (18547,4,1181,3) | 
GO:0043324 | pigment metabolic process involved in developmental pigmentation | 9.81E-4 | 3.41E-2 | 11.78 (18547,4,1181,3) | 
GO:0006726 | eye pigment biosynthetic process | 9.81E-4 | 3.4E-2 | 11.78 (18547,4,1181,3) | 
GO:0043474 | pigment metabolic process involved in pigmentation | 9.81E-4 | 3.39E-2 | 11.78 (18547,4,1181,3) | 
GO:0033489 | cholesterol biosynthetic process via desmosterol | 9.81E-4 | 3.39E-2 | 11.78 (18547,4,1181,3) | 
GO:0033490 | cholesterol biosynthetic process via lathosterol | 9.81E-4 | 3.38E-2 | 11.78 (18547,4,1181,3) | 
GO:0042471 | ear morphogenesis | 9.81E-4 | 3.37E-2 | 11.78 (18547,4,1181,3) | 
GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway | 9.81E-4 | 3.36E-2 | 11.78 (18547,4,1181,3) | 
GO:0072189 | ureter development | 9.81E-4 | 3.36E-2 | 11.78 (18547,4,1181,3) | 
GO:0042441 | eye pigment metabolic process | 9.81E-4 | 3.35E-2 | 11.78 (18547,4,1181,3) | 
GO:0021759 | globus pallidus development | 9.81E-4 | 3.34E-2 | 11.78 (18547,4,1181,3) | 
GO:0035720 | intraciliary anterograde transport | 9.81E-4 | 3.34E-2 | 11.78 (18547,4,1181,3) | 

## Function
GO term | Description | P-value | FDR q-value | Enrichment (N, B, n, b) |
 ---    |     ---     | ---     | ---         | ---                     |  
GO:0022857 | transmembrane transporter activity | 1.7E-39 | 7.85E-36 | 2.80 (18547,1037,1181,185) |  | 
GO:0005215 | transporter activity | 2.64E-37 | 6.1E-34 | 2.56 (18547,1239,1181,202) |  | 
GO:0015075 | ion transmembrane transporter activity | 7.21E-37 | 1.11E-33 | 2.93 (18547,869,1181,162) | 
GO:0015318 | inorganic molecular entity transmembrane transporter activity | 6.08E-34 | 7.02E-31 | 2.92 (18547,807,1181,150) | 
GO:0008324 | cation transmembrane transporter activity | 1.44E-33 | 1.33E-30 | 3.20 (18547,638,1181,130) | 
GO:0022890 | inorganic cation transmembrane transporter activity | 1.31E-31 | 1.01E-28 | 3.23 (18547,589,1181,121) | 
GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 6.96E-31 | 4.59E-28 | 3.88 (18547,376,1181,93) | 
GO:0015078 | proton transmembrane transporter activity | 7.78E-26 | 4.49E-23 | 5.97 (18547,129,1181,49) | 
GO:0022804 | active transmembrane transporter activity | 3.43E-21 | 1.76E-18 | 3.35 (18547,356,1181,76) | 
GO:0004129 | cytochrome-c oxidase activity | 2.77E-15 | 1.28E-12 | 10.68 (18547,25,1181,17) | 
GO:0016676 | oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor | 2.77E-15 | 1.16E-12 | 10.68 (18547,25,1181,17) | 
GO:0015002 | heme-copper terminal oxidase activity | 2.77E-15 | 1.07E-12 | 10.68 (18547,25,1181,17) | 
GO:0016675 | oxidoreductase activity, acting on a heme group of donors | 7.52E-15 | 2.68E-12 | 10.27 (18547,26,1181,17) | 
GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism | 9.5E-15 | 3.14E-12 | 12.93 (18547,17,1181,14) | 
GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism | 4.2E-13 | 1.29E-10 | 8.08 (18547,35,1181,18) | 
GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 4.51E-13 | 1.3E-10 | 4.41 (18547,114,1181,32) | 
GO:0019829 | cation-transporting ATPase activity | 5E-13 | 1.36E-10 | 5.80 (18547,65,1181,24) | 
GO:0022853 | active ion transmembrane transporter activity | 7.39E-13 | 1.9E-10 | 5.71 (18547,66,1181,24) | 
GO:0042625 | ATPase coupled ion transmembrane transporter activity | 7.39E-13 | 1.8E-10 | 5.71 (18547,66,1181,24) | 
GO:0008509 | anion transmembrane transporter activity | 1.06E-12 | 2.45E-10 | 2.81 (18547,319,1181,57) | 
GO:0015399 | primary active transmembrane transporter activity | 2.68E-12 | 5.89E-10 | 4.15 (18547,121,1181,32) | 
GO:0015405 | P-P-bond-hydrolysis-driven transmembrane transporter activity | 2.68E-12 | 5.63E-10 | 4.15 (18547,121,1181,32) | 
GO:0043492 | ATPase activity, coupled to movement of substances | 4.2E-12 | 8.44E-10 | 3.99 (18547,130,1181,33) | 
GO:0015291 | secondary active transmembrane transporter activity | 2.38E-11 | 4.59E-9 | 3.01 (18547,235,1181,45) | 
GO:0046873 | metal ion transmembrane transporter activity | 5.06E-11 | 9.35E-9 | 2.37 (18547,438,1181,66) | 
GO:0015238 | drug transmembrane transporter activity | 2.15E-10 | 3.82E-8 | 4.21 (18547,97,1181,26) | 
GO:0015293 | symporter activity | 3.69E-10 | 6.32E-8 | 3.49 (18547,144,1181,32) | 
GO:0015081 | sodium ion transmembrane transporter activity | 7.73E-10 | 1.28E-7 | 3.40 (18547,148,1181,32) | 
GO:0016887 | ATPase activity | 2.49E-9 | 3.96E-7 | 2.22 (18547,438,1181,62) | 
GO:0042623 | ATPase activity, coupled | 4.68E-9 | 7.22E-7 | 2.36 (18547,353,1181,53) | 
GO:0016758 | transferase activity, transferring hexosyl groups | 1.3E-8 | 1.94E-6 | 2.78 (18547,209,1181,37) | 
GO:0015294 | solute:cation symporter activity | 1.76E-8 | 2.55E-6 | 3.70 (18547,102,1181,24) | 
GO:0008514 | organic anion transmembrane transporter activity | 2.53E-8 | 3.55E-6 | 2.76 (18547,205,1181,36) | 
GO:0000030 | mannosyltransferase activity | 2.99E-8 | 4.06E-6 | 6.98 (18547,27,1181,12) | 
GO:0009055 | electron transfer activity | 5.74E-8 | 7.59E-6 | 3.49 (18547,108,1181,24) | 
GO:0140101 | catalytic activity, acting on a tRNA | 4.64E-7 | 5.96E-5 | 3.14 (18547,120,1181,24) | 
GO:0015267 | channel activity | 5.57E-7 | 6.96E-5 | 1.98 (18547,451,1181,57) | 
GO:0022803 | passive transmembrane transporter activity | 5.99E-7 | 7.28E-5 | 1.98 (18547,452,1181,57) | 
GO:0003824 | catalytic activity | 6.15E-7 | 7.29E-5 | 1.21 (18547,5640,1181,435) | 
GO:0004812 | aminoacyl-tRNA ligase activity | 6.32E-7 | 7.31E-5 | 5.10 (18547,40,1181,13) | 
GO:0016875 | ligase activity, forming carbon-oxygen bonds | 6.32E-7 | 7.13E-5 | 5.10 (18547,40,1181,13) | 
GO:0016757 | transferase activity, transferring glycosyl groups | 8.33E-7 | 9.17E-5 | 2.28 (18547,275,1181,40) | 
GO:0090482 | vitamin transmembrane transporter activity | 9.08E-7 | 9.77E-5 | 6.54 (18547,24,1181,10) | 
GO:0008177 | succinate dehydrogenase (ubiquinone) activity | 1.04E-6 | 1.09E-4 | 15.70 (18547,5,1181,5) | 
GO:0000104 | succinate dehydrogenase activity | 1.04E-6 | 1.07E-4 | 15.70 (18547,5,1181,5) | 
GO:0015370 | solute:sodium symporter activity | 1.99E-6 | 2E-4 | 3.71 (18547,72,1181,17) | 
GO:0005328 | neurotransmitter:sodium symporter activity | 2.19E-6 | 2.15E-4 | 6.04 (18547,26,1181,10) | 
GO:0051184 | cofactor transmembrane transporter activity | 2.44E-6 | 2.35E-4 | 6.73 (18547,21,1181,9) | 
GO:0005342 | organic acid transmembrane transporter activity | 3.13E-6 | 2.96E-4 | 2.70 (18547,151,1181,26) | 
GO:0046943 | carboxylic acid transmembrane transporter activity | 3.13E-6 | 2.9E-4 | 2.70 (18547,151,1181,26) | 
GO:0005216 | ion channel activity | 4E-6 | 3.62E-4 | 1.94 (18547,412,1181,51) | 
GO:0051539 | 4 iron, 4 sulfur cluster binding | 5.9E-6 | 5.24E-4 | 4.60 (18547,41,1181,12) | 
GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor | 5.9E-6 | 5.15E-4 | 13.09 (18547,6,1181,5) | 
GO:0022838 | substrate-specific channel activity | 8.45E-6 | 7.23E-4 | 1.89 (18547,423,1181,51) | 
GO:0015296 | anion:cation symporter activity | 1.06E-5 | 8.9E-4 | 6.61 (18547,19,1181,8) | 
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 1.2E-5 | 9.92E-4 | 3.79 (18547,58,1181,14) | 
GO:0005261 | cation channel activity | 1.22E-5 | 9.87E-4 | 2.03 (18547,317,1181,41) | 
GO:0015103 | inorganic anion transmembrane transporter activity | 1.31E-5 | 1.05E-3 | 2.62 (18547,144,1181,24) | 
GO:0016491 | oxidoreductase activity | 2.82E-5 | 2.21E-3 | 1.61 (18547,731,1181,75) | 
GO:0015377 | cation:chloride symporter activity | 2.86E-5 | 2.21E-3 | 6.87 (18547,16,1181,7) | 
GO:0051540 | metal cluster binding | 3.28E-5 | 2.49E-3 | 3.49 (18547,63,1181,14) | 
GO:0051536 | iron-sulfur cluster binding | 3.28E-5 | 2.45E-3 | 3.49 (18547,63,1181,14) | 
GO:0005201 | extracellular matrix structural constituent | 3.39E-5 | 2.48E-3 | 2.42 (18547,162,1181,25) | 
GO:0016874 | ligase activity | 3.54E-5 | 2.56E-3 | 2.53 (18547,143,1181,23) | 
GO:0016462 | pyrophosphatase activity | 3.6E-5 | 2.56E-3 | 1.53 (18547,913,1181,89) | 
GO:0016817 | hydrolase activity, acting on acid anhydrides | 4.06E-5 | 2.84E-3 | 1.53 (18547,916,1181,89) | 
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.06E-5 | 2.8E-3 | 1.53 (18547,916,1181,89) | 
GO:1901682 | sulfur compound transmembrane transporter activity | 4.47E-5 | 3.04E-3 | 4.49 (18547,35,1181,10) | 
GO:0015108 | chloride transmembrane transporter activity | 4.75E-5 | 3.18E-3 | 2.86 (18547,99,1181,18) | 
GO:0005326 | neurotransmitter transporter activity | 6.56E-5 | 4.33E-3 | 3.70 (18547,51,1181,12) | 
GO:0017111 | nucleoside-triphosphatase activity | 6.81E-5 | 4.43E-3 | 1.53 (18547,865,1181,84) | 
GO:0015373 | anion:sodium symporter activity | 7.66E-5 | 4.92E-3 | 7.25 (18547,13,1181,6) | 
GO:0036442 | proton-exporting ATPase activity | 9.37E-5 | 5.93E-3 | 4.56 (18547,31,1181,9) | 
GO:0022836 | gated channel activity | 1.16E-4 | 7.23E-3 | 1.86 (18547,338,1181,40) | 
GO:0008375 | acetylglucosaminyltransferase activity | 1.19E-4 | 7.32E-3 | 3.49 (18547,54,1181,12) | 
GO:0045504 | dynein heavy chain binding | 1.27E-4 | 7.71E-3 | 6.73 (18547,14,1181,6) | 
GO:0008194 | UDP-glycosyltransferase activity | 1.55E-4 | 9.32E-3 | 2.35 (18547,147,1181,22) | 
GO:0015171 | amino acid transmembrane transporter activity | 1.79E-4 | 1.06E-2 | 3.01 (18547,73,1181,14) | 
GO:0015378 | sodium:chloride symporter activity | 2E-4 | 1.17E-2 | 7.85 (18547,10,1181,5) | 
GO:0072349 | modified amino acid transmembrane transporter activity | 2E-4 | 1.16E-2 | 6.28 (18547,15,1181,6) | 
GO:0048037 | cofactor binding | 2.51E-4 | 1.43E-2 | 1.65 (18547,494,1181,52) | 
GO:0001103 | RNA polymerase II repressing transcription factor binding | 2.61E-4 | 1.47E-2 | 4.04 (18547,35,1181,9) | 
GO:0003674 | molecular_function | 2.94E-4 | 1.64E-2 | 1.03 (18547,16941,1181,1110) | 
GO:0005200 | structural constituent of cytoskeleton | 3.08E-4 | 1.7E-2 | 2.64 (18547,95,1181,16) | 
GO:0002161 | aminoacyl-tRNA editing activity | 3.47E-4 | 1.89E-2 | 7.14 (18547,11,1181,5) | 
GO:0005247 | voltage-gated chloride channel activity | 3.47E-4 | 1.86E-2 | 7.14 (18547,11,1181,5) | 
GO:1901505 | carbohydrate derivative transmembrane transporter activity | 3.57E-4 | 1.9E-2 | 3.57 (18547,44,1181,10) | 
GO:0046961 | proton-transporting ATPase activity, rotational mechanism | 4.14E-4 | 2.17E-2 | 4.78 (18547,23,1181,7) | 
GO:0015179 | L-amino acid transmembrane transporter activity | 4.26E-4 | 2.21E-2 | 3.26 (18547,53,1181,11) | 
GO:0015079 | potassium ion transmembrane transporter activity | 4.39E-4 | 2.26E-2 | 2.19 (18547,158,1181,22) | 
GO:0015232 | heme transporter activity | 4.9E-4 | 2.49E-2 | 8.97 (18547,7,1181,4) | 
GO:0045503 | dynein light chain binding | 7.25E-4 | 3.64E-2 | 4.40 (18547,25,1181,7) | 
GO:0030554 | adenyl nucleotide binding | 7.54E-4 | 3.75E-2 | 1.31 (18547,1530,1181,128) | 
GO:0005272 | sodium channel activity | 7.57E-4 | 3.72E-2 | 3.53 (18547,40,1181,9) | 
GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity | 9.3E-4 | 4.53E-2 | 7.85 (18547,8,1181,4) | 
GO:0000213 | tRNA-intron endonuclease activity | 9.81E-4 | 4.73E-2 | 11.78 (18547,4,1181,3) | 
GO:0032217 | riboflavin transmembrane transporter activity | 9.81E-4 | 4.68E-2 | 11.78 (18547,4,1181,3) | 
GO:0071077 | adenosine 3',5'-bisphosphate transmembrane transporter activity | 9.81E-4 | 4.63E-2 | 11.78 (18547,4,1181,3) | 
GO:0015234 | thiamine transmembrane transporter activity | 9.81E-4 | 4.58E-2 | 11.78 (18547,4,1181,3) | 
GO:0017018 | myosin phosphatase activity | 9.81E-4 | 4.54E-2 | 11.78 (18547,4,1181,3) | 
